DNA Mismatch Repair Happens Only During A Brief Window of Opportunity

 

December 20, 2011  |  

In eukaryotes – the group of organisms that include humans – a key to survival is the ability of certain proteins to quickly and accurately repair genetic errors that occur when DNA is replicated to make new cells.

In a paper published in the December 23, 2011 issue of the journal Science, researchers at the Ludwig Institute for Cancer Research and the University of California, San Diego School of Medicine have solved part of the mystery of how these proteins do their job, a process called DNA mismatch repair (MMR).

“One of the major questions in MMR is how MMR proteins figure out which base in a DNA mispair is the wrong one,” said Ludwig Institute assistant investigator Christopher D. Putnam, PhD, an adjunct assistant professor of medicine at UC San Diego. “For example, if guanine (G) is inappropriately in a base-pair with thymine (T), is the G or the T the error? Picking the wrong base results in mutations, not fixes.”

Using Saccharomyces cerevisiae, or baker’s yeast, as their model organism, the researchers, led by Richard D. Kolodner, PhD, Ludwig Institute investigator and UCSD professor of medicine and cellular and molecular medicine, discovered that newly replicated DNA produces a temporary signal for 10 to 15 minutes after replication which helps identify it as new – and thus a potential subject for MMR. 

The actual signal was not identified, but Putnam said it might be tell-tale nicks in single-stranded DNA or certain proteins associated with replication. The scientists are working to pinpoint the precise signal. 

The findings, combined with earlier, published work that visualized MMR in a living cell for the first time, more fully explains how eukaryotes eliminate DNA replication errors, which can result in defects and the development of cancers.

“How eukaryotes identify the newly synthesized strand of DNA is a mystery that has persisted for at least 30 years,” said Putnam. “These findings really change our ideas of how MMR works,” said Putnam.

Co-authors include Hans Hombauer and Anjana Srivatsan of the Ludwig Institute for Cancer Research, UCSD Departments of Medicine and Cellular and Molecular Medicine, Institute of Genomic Medicine and UC San Diego Moores Cancer Center.

Funding for this research came from the National Institutes of Health.

# # #

Media Contact: Scott LaFee, 619-543-6163, slafee@ucsd.edu




Media Contact

Share This Article


Related News

11/20/2017
The UC San Diego Health International Patient Program was recognized as the 2017 Medical Provider of the Year by the International Travel & Health Insurance Journal (ITIJ). ITIJ recognizes leading hea ...
11/16/2017
That “to do” list of chores and errands could actually provide a variety of health benefits, according to researchers at the University of California San Diego School of Medicine. The study, published ...
11/15/2017
UC San Diego Health has expanded its treatment of rare brain tumors by launching a specialized program in the diagnosis and treatment of acoustic neuromas and complex skull base tumors. The new progra ...
11/14/2017
In an unprecedented move, UC San Diego Health and UCI Health have formed a strategic partnership to increase operational efficiencies and decrease patient care costs by sharing a single electronic med ...



Follow Us